Key result
Orthopaedic devices approved 10 years ago were more likely to be unavailable than those approved 5 years ago (47% vs 25%), mostly due to poor market performance rather than safety problems (2%).
Why the study?
What is the natural history, including availability and safety, of new orthopaedic devices 5 and 10 years after FDA approval?
Cohort (n=100)
What is the natural history, including availability and safety, of new orthopaedic devices 5 and 10 years after FDA approval?
Absolute Event Rate: 47% vs 25%
Approximately half of new orthopaedic devices are no longer available 10 years after FDA approval, primarily due to poor market performance rather than safety issues.
Many orthopaedic devices become unavailable by 10 years post-approval, rarely for safety reasons; leaves open questions on post-market surveillance and selection criteria.
Each year, hundreds of new devices and implants are introduced for orthopaedic surgeons. However, the proportion of new devices which ultimately will be successful is unknown. We investigated the natural history of new devices introduced to the orthopaedic market. From a list of all devices approved for use by the Food & Drug Administration 5 and 10 years before, a cohort of 100 devices was randomly selected using a random number list. Companies were contacted regarding the safety record and current availability of these devices. The company response rate was 93%. Forty-seven percent of devices approved 10 years ago and 25% of devices approved 5 years ago no longer were on the market. Of the 55 companies studied, 18 (33%) were out of business and their devices no longer were available. Devices approved 10 years ago were more likely to be unavailable than devices approved 5 years ago. Devices introduced by smaller companies were more likely to be unavailable. The majority of unavailable devices were discontinued not for clinical problems, but for poor market performance. Only 2% of devices studied had safety problems. Approximately 50% of devices approved for introduction to the orthopaedic marketplace no longer are available 10 years later. However, major device-related problems seem uncommon.
No takes yet. Share an insight, caveat, or question.
Bhattacharyya et al. (2006) conducted a cohort in Orthopaedic devices (n=100). Orthopaedic devices approved 10 years ago vs. Orthopaedic devices approved 5 years ago was evaluated on Device no longer on the market. Orthopaedic devices approved 10 years ago were more likely to be unavailable than those approved 5 years ago (47% vs 25%), mostly due to poor market performance rather than safety problems (2%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: